KRS Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
8,373
+40
| +0.5% | +$7.43K | 1.04% | 19 |
|
|
2025
Q1 | $1.75M | Sell |
8,333
-26
| -0.3% | -$5.45K | 1.39% | 11 |
|
|
2024
Q4 | $1.49M | Buy |
8,359
+31
| +0.4% | +$5.51K | 1.05% | 19 |
|
|
2024
Q3 | $1.64M | Sell |
8,328
-453
| -5% | -$89.5K | 1.2% | 14 |
|
|
2024
Q2 | $1.51M | Sell |
8,781
-223
| -2% | -$38.3K | 1.13% | 16 |
|
|
2024
Q1 | $1.64M | Sell |
9,004
-690
| -7% | -$126K | 1.32% | 13 |
|
|
2023
Q4 | $1.5M | Sell |
9,694
-260
| -3% | -$40.3K | 1.4% | 13 |
|
|
2023
Q3 | $1.48M | Buy |
9,954
+284
| +3% | +$42.3K | 1.58% | 11 |
|
|
2023
Q2 | $1.3M | Buy |
9,670
+25
| +0.3% | +$3.37K | 1.3% | 13 |
|
|
2023
Q1 | $1.54M | Buy |
9,645
+74
| +0.8% | +$11.8K | 1.73% | 8 |
|
|
2022
Q4 | $1.55M | Buy |
9,571
+24
| +0.3% | +$3.88K | 2.11% | 6 |
|
|
2022
Q3 | $1.28M | Buy |
9,547
+47
| +0.5% | +$6.31K | 1.77% | 8 |
|
|
2022
Q2 | $1.46M | Sell |
9,500
-26
| -0.3% | -$3.98K | 2.07% | 5 |
|
|
2022
Q1 | $1.54M | Buy |
9,526
+22
| +0.2% | +$3.57K | 1.67% | 9 |
|
|
2021
Q4 | $1.29M | Buy |
+9,504
| New | +$1.29M | 1.1% | 17 |
|